Dr. Reddy's Laboratories (RDY) News Today → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free RDY Stock Alerts $68.26 -1.04 (-1.50%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 3:29 PM | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Sold by Robeco Institutional Asset Management B.V.Robeco Institutional Asset Management B.V. trimmed its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 18.2% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,367,899 shares of the company's stock after sellingMay 18 at 9:36 AM | marketbeat.comPanagora Asset Management Inc. Has $8.34 Million Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Panagora Asset Management Inc. grew its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 47.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 119,794 shares of the company's stocMay 16, 2024 | americanbankingnews.comDr. Reddy's Laboratories (NYSE:RDY) Downgraded to "Buy" at StockNews.comMay 10, 2024 | americanbankingnews.comDr. Reddy's Laboratories (NYSE:RDY) PT Raised to $81.00 at BarclaysMay 10, 2024 | americanbankingnews.comDr. Reddy's Laboratories (NYSE:RDY) Rating Increased to Strong-Buy at StockNews.comMay 9, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Raised to "Strong-Buy" at StockNews.comStockNews.com raised Dr. Reddy's Laboratories from a "buy" rating to a "strong-buy" rating in a research note on Wednesday.May 8, 2024 | finance.yahoo.comDr. Reddy’s Laboratories Limited (NYSE:RDY) Q4 2024 Earnings Call TranscriptMay 8, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Price Target Raised to $81.00Barclays upped their target price on shares of Dr. Reddy's Laboratories from $80.00 to $81.00 and gave the company an "overweight" rating in a report on Wednesday.May 7, 2024 | finance.yahoo.comDr. Reddy’s Q4 & Full Year FY24 Financial ResultsMay 7, 2024 | businesswire.comDr. Reddy's Q4 & Full Year FY24 Financial ResultsMay 7, 2024 | reuters.comIndia's Dr Reddy's beats Q4 profit estimatesMay 7, 2024 | markets.businessinsider.comHere's what Wall Street expects from Dr Reddys Laboratories's earnings reportMay 7, 2024 | sg.finance.yahoo.comIndia's Dr Reddy's beats Q4 profit view; names new CFOMay 6, 2024 | marketbeat.comFisher Asset Management LLC Boosts Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Fisher Asset Management LLC grew its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 125.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 204,672 shares of the company's stock after buying an additionalMay 3, 2024 | marketbeat.comQ1 2026 EPS Estimates for Dr. Reddy's Laboratories Limited (NYSE:RDY) Decreased by AnalystDr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Stock analysts at Zacks Research lowered their Q1 2026 earnings per share estimates for Dr. Reddy's Laboratories in a research note issued to investors on Wednesday, May 1st. Zacks Research analyst R. Department now expects that the compMay 3, 2024 | businesswire.comDr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.May 1, 2024 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Short Interest UpdateDr. Reddy's Laboratories Limited (NYSE:RDY - Get Free Report) was the target of a large increase in short interest in April. As of April 15th, there was short interest totalling 751,000 shares, an increase of 20.0% from the March 31st total of 625,800 shares. Based on an average daily trading volume, of 193,400 shares, the days-to-cover ratio is currently 3.9 days.April 30, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Lowered to "Buy" at StockNews.comStockNews.com downgraded shares of Dr. Reddy's Laboratories from a "strong-buy" rating to a "buy" rating in a report on Tuesday.April 30, 2024 | marketbeat.comDr. Reddy's Laboratories (RDY) to Release Earnings on TuesdayDr. Reddy's Laboratories (NYSE:RDY) will be releasing earnings before the market opens on Tuesday, May 7, Zacks reports.April 25, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up to $70.92Dr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up to $70.92April 23, 2024 | usatoday.comDr. Reddy’s Issues Voluntary Nationwide Recall of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg Due to Sub-PotencyApril 17, 2024 | marketbeat.comResearch Analysts Set Expectations for Dr. Reddy's Laboratories Limited's FY2026 Earnings (NYSE:RDY)Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Zacks Research decreased their FY2026 earnings per share estimates for shares of Dr. Reddy's Laboratories in a research note issued to investors on Tuesday, April 16th. Zacks Research analyst R. Department now expects that the company wiApril 7, 2024 | marketbeat.comVanguard Group Inc. Grows Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)Vanguard Group Inc. increased its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 2.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,048,152 shares of the company's sApril 5, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Upgraded to Strong-Buy by StockNews.comStockNews.com raised shares of Dr. Reddy's Laboratories from a "buy" rating to a "strong-buy" rating in a research note on Friday.March 29, 2024 | marketbeat.comAssenagon Asset Management S.A. Has $13.65 Million Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Assenagon Asset Management S.A. lifted its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 416.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 196,146 shares of the company's stock after buying an aMarch 25, 2024 | marketbeat.comWellington Management Group LLP Purchases 40,825 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Wellington Management Group LLP grew its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 40.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 141,154 shares of the company's stock after purchasing an additionalMarch 23, 2024 | marketbeat.comAikya Investment Management Ltd Takes $75.85 Million Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Aikya Investment Management Ltd bought a new stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 1,096,573 shares of the company's stock, valued aMarch 22, 2024 | finance.yahoo.comPharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in IndiaMarch 22, 2024 | marketbeat.comDeutsche Bank AG Reduces Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Deutsche Bank AG decreased its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 24.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 86,577 shares of the company's stock after selling 28,469 shares duringMarch 19, 2024 | businesswire.comDr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UKMarch 15, 2024 | marketbeat.comZacks Research Research Analysts Reduce Earnings Estimates for Dr. Reddy's Laboratories Limited (NYSE:RDY)Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Equities research analysts at Zacks Research decreased their Q3 2026 earnings estimates for Dr. Reddy's Laboratories in a research note issued on Wednesday, March 13th. Zacks Research analyst R. Department now forecasts that the companyMarch 14, 2024 | marketbeat.comWalleye Capital LLC Makes New $7.43 Million Investment in Dr. Reddy's Laboratories Limited (NYSE:RDY)Walleye Capital LLC bought a new position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 111,157 shares of the company's stock, valued at approximately $7,433,0March 12, 2024 | marketbeat.comSchroder Investment Management Group Has $10.04 Million Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Schroder Investment Management Group grew its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 62.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 150,165 shares of the company's stock after buying an addMarch 9, 2024 | marketbeat.comRoyal Bank of Canada Sells 738,856 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Royal Bank of Canada lessened its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 25.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,147,316 shares of the company's stock aftMarch 7, 2024 | marketbeat.comRamirez Asset Management Inc. Invests $1.68 Million in Dr. Reddy's Laboratories Limited (NYSE:RDY)Ramirez Asset Management Inc. bought a new position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The fund bought 25,127 shares of the company's stock, valued at approximately $1,680,000. Other larMarch 4, 2024 | marketbeat.comQube Research & Technologies Ltd Acquires 132,791 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Qube Research & Technologies Ltd raised its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 319.2% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 174,398 shares of the companFebruary 26, 2024 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Sold by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. cut its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 24.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 77,644 shares of the company's stock after sFebruary 24, 2024 | msn.comDr. Reddy's Laboratories Limited - Depositary Receipt () (RDY) Price Target Increased by 5.17% to 71.72February 23, 2024 | marketbeat.comQ1 2026 EPS Estimates for Dr. Reddy's Laboratories Limited Lowered by Analyst (NYSE:RDY)Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Zacks Research reduced their Q1 2026 EPS estimates for shares of Dr. Reddy's Laboratories in a note issued to investors on Wednesday, February 21st. Zacks Research analyst R. Department now expects that the company will earn $1.02 per shFebruary 23, 2024 | marketbeat.comDeutsche Bank AG Lowers Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Deutsche Bank AG cut its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 24.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 86,577 shares of the company's stock after sellFebruary 22, 2024 | msn.comGlobal Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising DemandFebruary 22, 2024 | msn.comNovo to face Wegovy competition in India as local versions loom: ReutersFebruary 22, 2024 | marketbeat.comDr. Reddy's Laboratories Limited to Post FY2024 Earnings of $3.95 Per Share, Zacks Research Forecasts (NYSE:RDY)Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Equities researchers at Zacks Research lifted their FY2024 earnings estimates for Dr. Reddy's Laboratories in a research note issued to investors on Wednesday, February 21st. Zacks Research analyst R. Department now expects that the compFebruary 21, 2024 | marketbeat.comAcadian Asset Management LLC Buys 57,293 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Acadian Asset Management LLC raised its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 26.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 270,260 shaFebruary 20, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Hits New 52-Week High at $76.57Dr. Reddy's Laboratories (NYSE:RDY) Hits New 12-Month High at $76.57February 20, 2024 | marketbeat.comAigen Investment Management LP Takes $763,000 Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Aigen Investment Management LP purchased a new stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 11,417 shares of the company's stock, vaFebruary 18, 2024 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Sold by Qtron Investments LLCQtron Investments LLC reduced its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 62.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 10,991 shares of the company's stocFebruary 16, 2024 | marketbeat.comQuantbot Technologies LP Sells 9,736 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Quantbot Technologies LP reduced its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 94.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 595 shares of the company's stock afterFebruary 12, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Sets New 12-Month High at $75.10Dr. Reddy's Laboratories (NYSE:RDY) Sets New 12-Month High at $75.10February 11, 2024 | marketbeat.comCampbell & CO Investment Adviser LLC Makes New $873,000 Investment in Dr. Reddy's Laboratories Limited (NYSE:RDY)Campbell & CO Investment Adviser LLC bought a new stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 13,049 shares of the Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. RDY Media Mentions By Week RDY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RDY News Sentiment▼0.600.42▲Average Medical News Sentiment RDY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RDY Articles This Week▼32▲RDY Articles Average Week Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: United Therapeutics News Sarepta Therapeutics News Catalent News Viatris News Roivant Sciences News Elanco Animal Health News Legend Biotech News Viking Therapeutics News BioMarin Pharmaceutical News BeiGene News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RDY) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
